Related references
Note: Only part of the references are listed.A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2014)
Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin- mediated relaxation after in vivo serelaxin treatment
Maria Jelinic et al.
FASEB JOURNAL (2014)
Executive Summary: Heart Disease and Stroke Statistics-2013 Update A Report From the American Heart Association
Alan S. Go et al.
CIRCULATION (2013)
Relaxin Suppresses Atrial Fibrillation by Reversing Fibrosis and Myocyte Hypertrophy and Increasing Conduction Velocity and Sodium Current in Spontaneously Hypertensive Rat Hearts
Ashish Parikh et al.
CIRCULATION RESEARCH (2013)
Outcomes and Care of Patients With Acute Heart Failure Syndromes and Cardiac Troponin Elevation
Juarez R. Braga et al.
CIRCULATION-HEART FAILURE (2013)
Forecasting the Impact of Heart Failure in the United States A Policy Statement From the American Heart Association
Paul A. Heidenreich et al.
CIRCULATION-HEART FAILURE (2013)
Acute Coronary Syndromes: Advances in Antithrombotics
Nilusha Gukathasan et al.
CURRENT ATHEROSCLEROSIS REPORTS (2013)
Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
Marco Metra et al.
EUROPEAN HEART JOURNAL (2013)
Thirty-Day Readmissions The Clock Is Ticking
Muthiah Vaduganathan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Relationship Between Hospital Readmission and Mortality Rates for Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, or Pneumonia
Harlan M. Krumholz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury
Massimo Collino et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
BLOOD HYPEROSMOLARITY AS A PREDICTOR OF MORTALITY IN PATIENTS AFTER ACUTE CORONARY SYNDROME: HOW DEHYDRATION AFFECTS THE PROGNOSIS OF OUR PATIENTS
Sem Briongos-Figuero et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Rehospitalization for Heart Failure Problems and Perspectives
Mihai Gheorghiade et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
John R. Teerlink et al.
LANCET (2013)
RELAXIN FAMILY PEPTIDES AND THEIR RECEPTORS
R. A. D. Bathgate et al.
PHYSIOLOGICAL REVIEWS (2013)
Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-β/Smad3 Signaling
Chiara Sassoli et al.
PLOS ONE (2013)
Design of the RELAXin in Acute Heart Failure Study
Piotr Ponikowski et al.
AMERICAN HEART JOURNAL (2012)
Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation
Marco Metra et al.
CLINICAL RESEARCH IN CARDIOLOGY (2012)
The role of the kidney in heart failure
Marco Metra et al.
EUROPEAN HEART JOURNAL (2012)
Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial
Andrew P. Ambrosy et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study
G. Michael Felker et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Minor Myocardial Damage is a Prevalent Condition in Patients With Acute Heart Failure Syndromes and Preserved Systolic Function With Long-Term Prognostic Implications. A Report From the CIAST-HF (Collaborative Italo-Argentinean Study on Cardiac Troponin T in Heart Failure) Study
Eduardo R. Perna et al.
JOURNAL OF CARDIAC FAILURE (2012)
Relaxin promotes growth and maturation of mouse neonatal cardiomyocytes in vitro: clues for cardiac regeneration
Silvia Nistri et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Biomarkers in acute heart failure-state of the art
Alan S. Maisel et al.
NATURE REVIEWS CARDIOLOGY (2012)
Relaxin Signals through a RXFP1-pERK-nNOS-NO-cGMP-Dependent Pathway to Up-Regulate Matrix Metalloproteinases: The Additional Involvement of iNOS
Bryna Suet Man Chow et al.
PLOS ONE (2012)
Sympathetically Mediated Changes in Capacitance Redistribution of the Venous Reservoir as a Cause of Decompensation
Catherine Fallick et al.
CIRCULATION-HEART FAILURE (2011)
Effects of Relaxin on Arterial Dilation, Remodeling, and Mechanical Properties
Kirk P. Conrad et al.
CURRENT HYPERTENSION REPORTS (2011)
Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial
Alan S. Maisel et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Angiogenic Growth Factors Are New and Essential Players in the Sustained Relaxin Vasodilatory Pathway in Rodents and Humans
Jonathan T. McGuane et al.
HYPERTENSION (2011)
Relaxin Ameliorates Hypertension and Increases Nitric Oxide Metabolite Excretion in Angiotensin II But Not Nω-Nitro-L-Arginine Methyl Ester Hypertensive Rats
Jennifer M. Sasser et al.
HYPERTENSION (2011)
Relaxin remodels fibrotic healing following myocardial infarction
Chrishan S. Samuel et al.
LABORATORY INVESTIGATION (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Relaxin inhibits early steps in vascular inflammation
Anna Brecht et al.
REGULATORY PEPTIDES (2011)
Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes Lessons Learned and Directions Forward
G. Michael Felker et al.
CIRCULATION-HEART FAILURE (2010)
Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure
Veli-Pekka Harjola et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate
Kevin Damman et al.
HEART (2010)
Unveiling the Vasodilatory Actions and Mechanisms of Relaxin
Kirk P. Conrad
HYPERTENSION (2010)
Troponin Elevation in Heart Failure Prevalence, Mechanisms, and Clinical Implications
Robb D. Kociol et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Cardiovascular effects of relaxin: from basic science to clinical therapy
Xiao-Jun Du et al.
NATURE REVIEWS CARDIOLOGY (2010)
Are All Readmissions Bad Readmissions?.
Eiran Z. Gorodeski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of β-arrestin recruitment
Gabrielle E. Callander et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Relaxin Reduces Fibrosis in Models of Progressive and Established Hepatic Fibrosis
Robert G. Bennett et al.
RELAXIN AND RELATED PEPTIDES: FIFTH INTERNATIONAL CONFERENCE (2009)
First Clinical Experience with Intravenous Recombinant Human Relaxin in Compensated Heart Failure
Thomas Dschietzig et al.
RELAXIN AND RELATED PEPTIDES: FIFTH INTERNATIONAL CONFERENCE (2009)
Relaxin as a Protective Substance in the Preserving Solution for Liver Transplantation Spectrophotometric in Vivo Imaging of Local Oxygen Supply in an Isolated Perfused Rat Liver Model
Markus U. Boehnert et al.
RELAXIN AND RELATED PEPTIDES: FIFTH INTERNATIONAL CONFERENCE (2009)
Reversal of Cardiac Fibrosis and Related Dysfunction by Relaxin Experimental Findings
Xiao-Jun Du et al.
RELAXIN AND RELATED PEPTIDES: FIFTH INTERNATIONAL CONFERENCE (2009)
An in Vitro Study of the Protective Effect of Relaxin on Brain Tissue under Ischemic Stress
Brian C. Wilson et al.
RELAXIN AND RELATED PEPTIDES: FIFTH INTERNATIONAL CONFERENCE (2009)
Hyperuricemia in acute heart failure. More than a simple spectator?
Anna L. Alimonda et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2
Ishanee Mookerjee et al.
FASEB JOURNAL (2009)
Vasodilators in the treatment of acute heart failure: what we know, what we don't
Marco Metra et al.
HEART FAILURE REVIEWS (2009)
Relaxin, a pleiotropic vasodilator for the treatment of heart failure
Sam L. Teichman et al.
HEART FAILURE REVIEWS (2009)
Intravenous Recombinant Human Relaxin in Compensated Heart Failure: A Safety, Tolerability, and Pharmacodynamic Trial
Thomas Dschietzig et al.
JOURNAL OF CARDIAC FAILURE (2009)
Acute Heart Failure Syndromes
Mihai Gheorghiade et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
Sharon Ann Hunt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study
John R. Teerlink et al.
LANCET (2009)
Relaxin and its role in the development and treatment of fibrosis
Robert G. Bennett
TRANSLATIONAL RESEARCH (2009)
The pathophysiology of acute heart failure - Is it all about fluid accumulation?
Gad Cotter et al.
AMERICAN HEART JOURNAL (2008)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008
Kenneth Dickstein et al.
EUROPEAN HEART JOURNAL (2008)
Fluid overload in acute heart failure - Re-distribution and other mechanisms beyond fluid accumulation
Gad Cotter et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Cardiac troponin I as prognostic marker in heart failure patients discharged from emergency department
Nicola Parenti et al.
INTERNAL AND EMERGENCY MEDICINE (2008)
Cardiac troponin and outcome in acute heart failure
W. Frank Peacock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Relaxin as a natural agent for vascular health
Daniele Bani
VASCULAR HEALTH AND RISK MANAGEMENT (2008)
Relaxin antagonizes hypertrophy and apoptosis in neonatal rat cardiomyocytes
Xiao-lei Moore et al.
ENDOCRINOLOGY (2007)
Relation between cardiac troponin I and mortality in acute decompensated heart failure
John J. You et al.
AMERICAN HEART JOURNAL (2007)
Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure
Krista Siirila-Waris et al.
EUROPEAN HEART JOURNAL (2006)
Influence of recombinant human relaxin on renal hemodynamics in healthy volunteers
Marie C. Smith et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats
DO Debrah et al.
HYPERTENSION (2005)
Overview of current noninodilator therapies for acute heart failure syndromes
WG Stough et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway
MHJ Heeg et al.
KIDNEY INTERNATIONAL (2005)
Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure
ER Perna et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Is the pregnancy hormone relaxin an important player in human heart failure?
M Kupari et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Effects of relaxin on systemic arterial hemodynamics and mechanical properties in conscious rats: sex dependency and dose response
DO Debrah et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure
CH Del Carlo et al.
JOURNAL OF CARDIAC FAILURE (2004)
Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo
CS Samuel et al.
ENDOCRINOLOGY (2004)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial
CB Granger et al.
LANCET (2003)
Inhibition of markers of hepatic stellate cell activation by the hormone relaxin
RG Bennett et al.
BIOCHEMICAL PHARMACOLOGY (2003)
N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure
C Fisher et al.
HEART (2003)
The pregnancy hormone relaxin is a player in human heart failure
T Dschietzig et al.
FASEB JOURNAL (2001)
Cardiac troponin I as diagnostic and prognostic marker in severe heart failure
L La Vecchia et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2000)
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure -: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)
Å Hjalmarson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
